Previous studies have demonstrated that fluoxetine administration decreases mitogeninduced T lymphocyte proliferation. The present studies were carried out to determine which receptor subtype(s) was involved and whether these effects on lymphocyte responses were centrally or peripherally mediated. Two hours following administration of the 5-HT 1A agonist 8-OH-DPAT (1 mg/kg), there was no change in lymphocyte proliferation responses, whereas the 5-HT 2 agonist DOI (2.5 mg/kg) significantly decreased (80%) proliferation. Similarly, pretreatment with the 5-HT 2 antagonists ritanserin (5 mg/kg, 30 min) or ketanserin (5 mg/kg, 1 h) was found to completely antagonize the effects of fluoxetine on lymphocyte proliferation. Consistent with central 5-HT 2 receptor involvement, microinjection of DOI (50 µg) resulted in a decrease in lymphocyte proliferation similar to that observed following systemic administration. Furthermore, central administration of ketanserin (20 µg) prevented the suppressive effects of systemic fluoxetine. Collectively, these results suggest that decreases in mitogen-induced lymphocyte proliferation following acute fluoxetine administration was due to indirect effects of fluoxetine following the activation of central 5-HT 2 receptors.
INTRODUCTION
The direct effect of serotonin on the function of immune cells has been widely studied utilizing in vitro models. Serotonin has been shown to have both immune enhancing (Eugen-Olsen et al., 1997; Nordlind & Sundstrom, 1988) and suppressing (Bonnet, Lespinats, & Burtin, 1984; Khan, Bhardwaj, Malla, Wattal, & Agarwal, 1986; Nannmark, Sennerby, Bjursten, Skolnik, & Bagge, 1992; Nordlind et al., 1988; Slauson, Walker, Kristensen, Wang, & De Weck, 1984; Sternberg, Wedner, Leung, & Parker, 1987) effects in these models. Although not completely characterized, activation of 5-HT 1A receptors in vitro has been shown to enhance immune cell function (Afzelius, Nielsen, Hofmann, & Nielsen, 1997; Aune, Golden, & McGrath, 1994; Hellstrand & Hermodsson, 1987; Iken, Chheng, Fargin, Goulet, & Kouassi, 1995) , whereas activation of 5-HT 2 receptors in vitro has been shown to decrease immune cell function (Nordlind, Sundstrom, & Bondesson, 1992; Arzi, Costas, Finkielman, & Nahmod, 1991; Garsaddi, Mandi, Regely, Tarodi, & Beladi, 1993; Sternberg, Trial, & Parker, 1986) . While the presence of 5-HT 1A and 5-HT 2 serotonin receptors on immune cells, including T lymphocytes, has been demonstrated pharmacologically (Iken et al., 1995; Choquet & Korn, 1988; Aune et al., 1993; Ameisen, Meade, & Askenase, 1989; Hellstrand & Hermodsson, 1993; Sternberg et al., 1986 Sternberg et al., , 1987 Sil- 
